Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study
Go back to Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study| Nanometrics, Inc. (NASDAQ: NANO) | Delayed: 35.33 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $35.33 | 52 Week High | $23.88 | |||
| Open | $34.26 | 52 Week Low | $12.50 | |||
| Day High | $35.33 | P/E | N/A | |||
| Day Low | $35.33 | EPS | $-0.61 | |||
| Volume | 9,709 | |||||
| (NASDAQ: NBTX) | Delayed: 35.23 -1.04 (2.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.27 | 52 Week High | $ | |||
| Open | $34.11 | 52 Week Low | $ | |||
| Day High | $38.00 | P/E | N/A | |||
| Day Low | $34.06 | EPS | $ | |||
| Volume | 97,148 | |||||
